Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -16.79%298.51M | -13.07%200.29M | -6.50%100.55M | 47.52%487.71M | 44.85%358.73M | 43.20%230.41M | 28.62%107.55M | -41.85%330.6M | -46.49%247.66M | -54.20%160.9M |
Operating revenue | -16.79%298.51M | -13.07%200.29M | -6.50%100.55M | 47.52%487.71M | 44.85%358.73M | 43.20%230.41M | 28.62%107.55M | -41.85%330.6M | -46.49%247.66M | -54.20%160.9M |
Other operating revenue | ---- | 179.50%3.66M | ---- | -77.25%5.43M | ---- | -85.66%1.31M | ---- | 38.87%23.85M | ---- | -8.75%9.13M |
Total operating cost | -15.25%310.19M | -10.40%209.28M | -4.74%102.94M | 40.98%498.06M | 44.59%365.98M | 42.14%233.57M | 26.91%108.07M | -38.08%353.29M | -45.85%253.11M | -52.89%164.33M |
Operating cost | -17.22%264.44M | -13.75%177.13M | -8.14%87.46M | 51.69%433.44M | 49.60%319.45M | 50.41%205.36M | 30.11%95.21M | -39.96%285.74M | -44.96%213.54M | -53.04%136.53M |
Operating tax surcharges | 13.19%5.01M | 25.43%3.68M | 6.28%1.93M | -16.58%5.35M | -12.46%4.42M | -14.08%2.93M | -1.69%1.82M | -18.24%6.42M | -15.82%5.05M | -24.17%3.41M |
Operating expense | -32.68%7.82M | 0.17%5.57M | -25.32%2.62M | -2.32%17.47M | 13.03%11.61M | -25.54%5.56M | 4.58%3.51M | -45.29%17.89M | -62.37%10.27M | -64.76%7.46M |
Administration expense | 12.74%27M | 17.00%18.87M | 42.69%8.59M | 1.09%36.48M | 23.03%23.95M | 22.79%16.13M | 18.30%6.02M | 1.68%36.09M | -37.48%19.47M | -36.88%13.14M |
Financial expense | 45.85%-1.83M | 44.21%-1.34M | 46.95%-655.03K | 6.99%-3.94M | -7.41%-3.38M | -15.94%-2.4M | -27.80%-1.23M | 7.89%-4.24M | 14.97%-3.15M | 20.35%-2.07M |
-Interest expense (Financial expense) | --168.81 | --168.81 | ---- | -10.51%94.53K | ---- | ---- | ---- | -81.22%105.64K | ---- | ---- |
-Interest Income (Financial expense) | 44.05%-1.73M | 42.76%-1.24M | 41.37%-648.48K | -0.35%-3.76M | -13.77%-3.1M | -22.41%-2.17M | -26.46%-1.11M | -0.64%-3.74M | 4.50%-2.72M | 10.83%-1.77M |
Research and development | -21.92%7.75M | -10.36%5.37M | 9.07%2.99M | -18.82%9.25M | 25.29%9.93M | 2.45%5.99M | 3.72%2.74M | -50.94%11.39M | -57.72%7.92M | -58.86%5.85M |
Credit Impairment Loss | -51.91%187.38K | -56.99%122.5K | 69.13%40K | 98.17%2.84M | -18.35%389.63K | 71.02%284.82K | -79.70%23.65K | -26.75%1.43M | --477.19K | 645.81%166.54K |
Asset Impairment Loss | ---- | ---- | ---- | 78.70%-3.53M | ---- | ---- | ---- | -1,236.26%-16.59M | ---- | ---- |
Other net revenue | 3.51%11.1M | 109.93%8.46M | 67.38%1.94M | 254.55%12.32M | 109.54%10.73M | 37.84%4.03M | -39.60%1.16M | -189.38%-7.97M | 9.03%5.12M | 0.79%2.92M |
Asset deal income | 3,336.53%34.71K | 1,807.75%34.71K | --34.71K | 225.69%356.68K | 99.62%-1.07K | 101.09%1.82K | ---- | -7,183.26%-283.78K | ---283.78K | ---167.12K |
Other revenue | 5.25%10.88M | 121.81%8.31M | 64.28%1.86M | 69.47%12.66M | 109.88%10.34M | 28.01%3.74M | -37.00%1.13M | -8.85%7.47M | 6.35%4.93M | 1.59%2.93M |
Operating profit | -116.67%-578.96K | -161.00%-527.76K | -171.58%-454.65K | 106.43%1.97M | 1,142.63%3.47M | 271.47%865.19K | 66.00%635.11K | -546.47%-30.65M | -392.08%-333.13K | -109.38%-504.56K |
Add:Non operating Income | 121.04%1.84M | 766.10%1.68M | 3,533.99%1.11M | 387.84%2.66M | 25.79%831.28K | -68.78%194.32K | 71.35%30.5K | -83.31%544.41K | 1,030.15%660.83K | 14,290.21%622.47K |
Less:Non operating expense | --25.45K | --25.45K | --25.25K | ---- | ---- | ---- | ---- | -8.30%10K | 7,730.12%70.85K | ---- |
Total profit | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 115.36%4.63M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -397.70%-30.12M | 49.66%256.85K | -97.81%117.91K |
Less:Income tax cost | ---- | ---- | ---- | 176.53%1.78M | ---- | ---- | ---- | -271.55%-2.32M | ---- | ---- |
Net profit | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 110.26%2.85M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -417.16%-27.8M | 61.58%256.85K | -97.81%117.91K |
Net profit from continuing operation | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 110.26%2.85M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -417.16%-27.8M | 61.58%256.85K | -97.81%117.91K |
Net profit of parent company owners | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 110.26%2.85M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -417.16%-27.8M | 61.58%256.85K | -97.81%117.91K |
Earning per share | ||||||||||
Basic earning per share | -75.00%0.001 | 10.00%0.0011 | 0.00%0.0006 | 109.00%0.0027 | 1,900.00%0.004 | 900.00%0.001 | 50.00%0.0006 | -400.00%-0.03 | 100.00%0.0002 | -98.00%0.0001 |
Diluted earning per share | -75.00%0.001 | 10.00%0.0011 | 0.00%0.0006 | 109.00%0.0027 | 1,900.00%0.004 | 900.00%0.001 | 50.00%0.0006 | -400.00%-0.03 | 100.00%0.0002 | -98.00%0.0001 |
Other composite income | ||||||||||
Total composite income | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 110.26%2.85M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -417.16%-27.8M | 61.58%256.85K | -97.81%117.91K |
Total composite income of parent company owners | -71.35%1.23M | 6.64%1.13M | -5.58%628.47K | 110.26%2.85M | 1,575.91%4.3M | 798.55%1.06M | 66.24%665.61K | -417.16%-27.8M | 61.58%256.85K | -97.81%117.91K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | ZTE Accounting firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.